Amanote Research
Register
Sign In
Php139 - G-Ba Conditional Approvals in the Amnog Procedure: Impact on Hta Outcomes and Price
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1033
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
J. Dehnen
D. Petry
F. Kruse
J. Bercher
Publisher
Elsevier BV
Related search
Conditional Resolutions in the Amnog Early Benefit Assessment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php38 - Enzyme Replacement Therapies Within the German Hta (Amnog) Process
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php234 - Evaluating the Impact of Value Based Pricing (Vbp) and Hta on Price Levels in an Eu Context
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Impact of Brexit on Pharmaceuticals and HTA
PharmacoEconomics - Open
Health Policy
Pharmacology
Impact of Cigarette Price Increase on Health and Financing Outcomes in Vietnam
Gates Open Research
Genetics
Molecular Biology
Environmental
Biochemistry
Public Health
Microbiology
Health Policy
Medicine
Immunology
Occupational Health
Impact of Cigarette Price Increase on Health and Financing Outcomes in Vietnam
Pcn275 - How Do Hta Decisions for New Disease Conditions Impact Time to Price Changes?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Predicting Post-Amnog Rebate Outcomes for Oncology Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
“Market Withdrawals” of Medicines in Germany After AMNOG: A Comparison of HTA Ratings and Clinical Guideline Recommendations
Health Economics Review
Health Policy
